Tag: Oncimmune

March 6, 2022 Off

Oncimmune Holdings in new commercial contract with 10 companies

Oncimmune Holdings has signed a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing on the autoantibody profiling of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”).

September 20, 2021 Off

Oncimmune to evaluate autoantibody profiles

By Dino Mustafić

Oncimmune Holdings has signed an autoantibody profiling agreement with a leading global pharmaceutical company to evaluate the autoantibody profiles of patient samples in various autoimmune diseases.